We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+7.98%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.25B
AUM Growth
-$1.7B
Cap. Flow
-$2.08B
Cap. Flow %
-33.31%
Top 10 Hldgs %
54.24%
Holding
331
New
77
Increased
88
Reduced
65
Closed
73

Top Buys

Rank Stock Value
1
FIVN icon
FIVE9
FIVN
+$41.6M
2
NARI
Inari Medical, Inc. Common Stock
NARI
+$39M
3
DPZ icon
Domino's
DPZ
+$33.2M
4
INCY icon
Incyte
INCY
+$27.6M
5
HUM icon
Humana
HUM
+$26.5M

Top Sells

Rank Stock Value
1
NBIX icon
Neurocrine Biosciences
NBIX
+$109M
2
EXAS
Exact Sciences
EXAS
+$59.2M
3
SNY icon
Sanofi
SNY
+$49.7M
4
KDP icon
Keurig Dr Pepper
KDP
+$49.6M
5
GSK icon
GSK
GSK
+$39.9M

Sector Composition

Rank Sector Weight
1 Healthcare 41.55%
2 Consumer Discretionary 7.13%
3 Consumer Staples 5.35%
4 Technology 5.24%
5 Communication Services 0.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SHAK icon
26
Shake Shack
SHAK
$2.61B
$46.9M 0.75%
453,974
-125,930
-22% -$12.1M
PENN icon
27
PENN Entertainment
PENN
$2.67B
$45.2M 0.72%
2,394,310
-248,750
-9% -$4.74M
BCYC
28
Bicycle Therapeutics
BCYC
$270M
$44.3M 0.71%
1,956,000
-16,000
-0.8% -$369K
DPZ icon
29
Domino's
DPZ
$12.1B
$43.5M 0.7%
101,176
+76,415
+309% +$33.2M
DYN icon
30
Dyne Therapeutics
DYN
$4.71B
$41.5M 0.66%
1,155,204
+184,313
+19% +$7.34M
ALKS icon
31
Alkermes
ALKS
$8.31B
$40.5M 0.65%
1,448,654
-1,250,525
-46% -$33.3M
IMCR icon
32
Immunocore
IMCR
$1.65B
$39.3M 0.63%
1,264,000
+288,000
+30% +$10.5M
TMCI icon
33
Treace Medical Concepts
TMCI
$304M
$35.9M 0.57%
6,196,000
+836,000
+16% +$5.37M
IRWD icon
34
Ironwood Pharmaceuticals
IRWD
$728M
$33.8M 0.54%
8,200,000
+400,000
+5% +$2.15M
SNY icon
35
Sanofi
SNY
$103B
$33.4M 0.53%
580,000
-920,000
-61% -$49.7M
S icon
36
SentinelOne
S
$6.87B
$33.3M 0.53%
1,393,196
+898,561
+182% +$20.3M
VYGR icon
37
Voyager Therapeutics
VYGR
$181M
$30.4M 0.49%
5,200,000
– –
DDOG icon
38
Datadog
DDOG
$97.4B
$29.9M 0.48%
260,000
+60,817
+31% +$7.11M
TOST icon
39
Toast
TOST
$19B
$28.9M 0.46%
1,020,235
-342,334
-25% -$8.68M
ISRG icon
40
Intuitive Surgical
ISRG
$135B
$28.2M 0.45%
57,326
-13,901
-20% -$6.47M
SAM icon
41
Boston Beer
SAM
$1.94B
$27.7M 0.44%
95,807
-1,485
-2% -$414K
PRTA icon
42
Prothena Corp
PRTA
$436M
$27.6M 0.44%
1,650,000
+90,000
+6% +$1.94M
THS
43
DELISTED
Treehouse Foods
THS
$26.1M 0.42%
622,000
-161,000
-21% -$6.39M
DOCU
44
DocuSign
DOCU
$10.5B
$25M 0.4%
402,894
-195,027
-33% -$10.9M
AUTL
45
Autolus Therapeutics
AUTL
$484M
$24.9M 0.4%
6,872,000
+622,000
+10% +$2.48M
RIGL icon
46
Rigel Pharmaceuticals
RIGL
$693M
$24.9M 0.4%
1,536,000
-88,000
-5% -$1.03M
SXT icon
47
Sensient Technologies
SXT
$5.37B
$23.4M 0.37%
291,814
+25,009
+9% +$1.9M
LEVI icon
48
Levi Strauss
LEVI
$9.48B
$23.3M 0.37%
1,070,000
+723,000
+208% +$13.7M
PLNT icon
49
Planet Fitness
PLNT
$4.45B
$22.3M 0.36%
274,369
-39,845
-13% -$3.12M
TXRH icon
50
Texas Roadhouse
TXRH
$13.8B
$22.1M 0.35%
125,076
-4,817
-4% -$813K
1
2
3 4 5

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return

Armistice Capital's Q3 2024 Portfolio in Review

As of Q3 2024, Armistice Capital held 331 positions worth $6.25B, down 21% from $7.95B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Armistice Capital withdrew a net $2.08B in Q3 2024, closing 73 positions and reducing 65 holdings. Its most notable exit was Exact Sciences, an estimated $59.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

Against the trend, Armistice Capital opened a new position in Paramount Global Class B worth $21.2M.

  • Armistice Capital's largest Q3 2024 buy was Paramount Global Class B: 2,000,000 shares worth $21.2M.
  • Armistice Capital added most to FIVE9 in Q3 2024, an estimated $41.6M increase.
  • Armistice Capital's biggest Q3 2024 reduction was Neurocrine Biosciences, cutting an estimated $109M.
  • Armistice Capital fully exited Exact Sciences in Q3 2024, selling an estimated $59.2M.
  • Armistice Capital's ten largest holdings make up 54% of its $6.25B portfolio in Q3 2024.
  • Armistice Capital opened 77 new positions and closed 73 in Q3 2024.
  • Armistice Capital's portfolio value fell 21% quarter-over-quarter to $6.25B.

Based on Armistice Capital's 13F filing for Q3 2024, filed 14 Nov 2024.